Background illustration for clinical trials search

Ovarian Cancer Clinical Trials

Browse 1,660 ovarian cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

To Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of DAY301 in Participants With Locally Advanced or Metastatic Solid Tumors

for
Advanced or Metastatic Solid Tumors
Location: New Haven CT, New York NY, Toronto, Sarasota FL,
Sponsor: Day One Biopharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT06752681

Phase 1, Recruiting

Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)

for
Advanced Malignant Solid Neoplasm,
Location: Boston MA, New Haven CT, Trumbull CT, New York NY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06311214

Phase 2, Recruiting

Zanubrutinib With Pemetrexed to Treat Relapsed/Refractory Primary and Secondary Central Nervous System (CNS) Lymphomas

for
Primary Central Nervous System Lymphoma,
Location: Miami FL
Sponsor: Baptist Health South Florida

Sex: All

Age: 18+

Code: NCT05681195

Phase 2, Recruiting

PRecision Oncology Evidence Development in Cancer Treatment - Clinical: PREDiCTc

for
Cancer
Location: Vancouver
Sponsor: British Columbia Cancer Agency

Sex: All

Age: 18+

Code: NCT04814095

Recruiting

Clinical Nurse Specialist Led Early Palliative Survivorship Care for Patients With Advanced Cancer

for
Solid Tumor, Adult, Metastasis
Location: West Islip NY
Sponsor: Good Samaritan Hospital Medical Center, New York

Sex: All

Age: 21+

Code: NCT05947695

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection

for
Prostate Cancer,
Location: Miami FL, Atlanta GA, Omaha NE
Sponsor: Blue Earth Therapeutics Ltd

Sex: Male

Age: 18+

Code: NCT05413850

Phase 1, Phase 2, Recruiting

ASTX727 in Recurrent/Progressive Non-enhancing IDH Mutant Gliomas

for
Neurological Cancer
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT03922555

Phase 1, Recruiting

Gadofosveset Trisodium (Ablavar, Gdfos) in Distinguishing Hemangiomas and Metastases: A Prospective Trial

for
Cancer, Metastases, Liver Neoplasms
Location: Toronto
Sponsor: Sunnybrook Health Sciences Centre

Sex: All

Age: 18+

Code: NCT02036008

Recruiting

Exercise Intervention in Adolescent and Young Adult Cancer Survivors

for
Long-term Effects Secondary to Cancer Therapy in Adults,
Location: Carmel IN, Indianapolis IN
Sponsor: Indiana University

Sex: All

Age: 15 - 39

Code: NCT04265638

Recruiting

Indocyanine Green (ICG) Guided Sentinel Lymph Node Mapping for Pediatric Visceral Solid Tumors

for
Solid Tumor
Location: Pittsburgh PA, Chicago IL, Memphis TN
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 0 - 20

Code: NCT05645523

Early Phase 1, Recruiting

A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy

for
Solid Tumors, Lymphoma
Location: Cleveland OH
Sponsor: Spectrum Pharmaceuticals, Inc

Sex: All

Age: 0 - 17

Code: NCT04570423

Phase 2, Recruiting

Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.

for
Solid Tumor, Lymphoma
Location: Morristown NJ, Chicago IL
Sponsor: MultiVir, Inc.

Sex: All

Age: 18+

Code: NCT03544723

Phase 2, Recruiting

First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors

for
Solid Tumors, Sarcoma
Location: Boston MA, New York NY, Nashville TN
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT06644755

Phase 1, Recruiting

Acceptance and Commitment Therapy and Compassion-Based Virtual Group Therapy to Improve Psychological Wellbeing in Patients With Cancer

for
Hematopoietic and Lymphoid System Neoplasm,
Location: Scottsdale AZ
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06246955

Recruiting

Generating Novel Translational and Therapeutic Strategies Based on a Multicenter, Pediatric and AYA Evolutionary Tumor Board (pedsETB)

for
Pediatric Cancer
Location: Hartford CT, Miami FL, Buffalo NY, Tampa FL,
Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: All

Age: 0+

Code: NCT06423950

Recruiting

JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors

for
Advanced Solid Tumor, Metastatic Solid Tumor
Location: Philadelphia PA, Fairfax VA, Durham NC, Orlando FL,
Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06108050

Phase 1, Recruiting

Non-invasive Liquid Biopsy Analysis of Epigenomics Signatures in Multiple Cancer Types

for
Diagnosis of Cancer of Various Organs
Location: San Diego CA
Sponsor: ClearNote Health

Sex: All

Age: 21 - 70+

Code: NCT03869814

Recruiting

Study of APR-1051 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: New Brunswick NJ, Fairfax VA, Cleveland OH, Houston TX,
Sponsor: Aprea Therapeutics

Sex: All

Age: 18+

Code: NCT06260514

Phase 1, Recruiting

A Study of JNJ-87890387 for Advanced Solid Tumors

for
Neoplasms, Advanced Solid Tumors
Location: Grand Rapids MI, Nashville TN
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06178614

Phase 1, Recruiting

Role of Gut Microbiome in Cancer Therapy

for
Hematopoietic and Lymphoid Cell Neoplasm,
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18 - 70+

Code: NCT05112614

Recruiting

What is ovarian cancer?

Ovarian cancer begins in or near the ovaries. About 9 in 10 cases are epithelial, and most of those are high grade serous tumors that research now shows usually start in the fallopian tubes rather than the ovary. Rarer types begin in the egg cells or in hormone producing cells. It is hard to catch early. The ovaries sit deep in the pelvis, and early symptoms like bloating, pelvic or back pain, feeling full quickly, and urinary urgency are vague and common. The most frequent sign at diagnosis is abdominal swelling from fluid, which means the cancer is already advanced.

Treatment has changed. Surgery to remove as much tumor as possible, followed by platinum chemotherapy, is still the foundation. Since 2014 PARP inhibitor pills have been used to delay recurrence in BRCA mutated and similar tumors, and testing every patient for these mutations is now standard. In 2022 the first antibody drug conjugate for ovarian cancer was approved for platinum resistant disease, with full approval in 2024. Prevention has moved too. Because most cancers start in the tubes, removing only the fallopian tubes during other pelvic surgery is being tested as a way to prevent cancer without early menopause.

Ovarian cancer shares its inherited risk genes with breast, pancreatic, and prostate cancer. Our cancer treatment guide explains how targeted therapies work.

Types of ovarian cancer clinical trials

How is ovarian cancer diagnosed and tested?

Who can participate in ovarian cancer clinical trials?

The stages of ovarian cancer, and why they matter for trials

How to enroll in an ovarian cancer clinical trial